Induced differentiation of human cord blood mesenchymal stem/progenitor cells into cardiomyocyte-like cellsin vitro

Abstract

The feasibility of using cord blood mesenchymal stem/progenitor cells (CB-MSPCs) to regenerate cardiomyocytes and the optimal inducing conditions were investigated. The CB mononuclear cells were cultured in low serum DMEM medium to produce an adherent layer. After expansion, the adherent cells were added into cardiomyocyte inducing medium supplemented with 5-azacytidine. Cardiogenic specific contractile protein troponin T staining was performed to identify the cardiomyocyte-like cells. The results showed that the frequency of CB-MSPCs clones in CB mononuclear cells was 0.5×10⁻⁶ and about 1.3×10⁷-fold expansion was achieved within 20 sub-cultivation. After cardiogenic induction, 70% CB-MSPCs was differentiated into cardiomyocyte-like cells. It was indicated that low serum culture could expand CB-MSPCs extensively and the expanded CB-MSPCs could be induced to differentiate into cardiomyocyte-like cells in high efficiency.

Keywords

cord blood / mesenchymal stem/progenitor cell / differentiation / cardiomyocyte / 5-azacytidine

References

[1] PittengerM F, MackayA M, BeckC B, et al. . Multi-lineage potential of adult human mesenchymal stem cells. Science, 1999, 284143-143

[2] EricesA, CongetP, MinguellJ J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Hematol, 2000, 109235-235

[3] VerfaillieC. Direct contact between progenitors and stoma is not required for human in vitro hematopoiesis. Blood, 1992, 792821-2821

[4] ReysM, LundT, LenvikT, et al. . Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood, 2001, 982615-2615

[5] MokinoS, FududaK, MiyoshiS, et al. . Cardiomyocyte can be generated from marrow stromal cell in vitro. J Clin Invest, 1999, 103697-697

[6] RosenthalN, TsaoL. Helping the heart to deal with stem cells. Nat Med, 2001, 7412-412

[7] SakaiT, LiR K, WeiselR D, et al. . Fetal cell transplantation: A comparison of three cell types. J Thorac Cardiovasc Surg, 1999, 118715-715

[8] TaylorD A, AtkinsB Z, HungspreugS, et al. . Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med, 1998, 4929-929

[9] ScorsinM, HagegeA, VilquinJ P, et al. . Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Candiovasc Surg, 2000, 1191167-1167

[10] KocherA A, SchusterM D, SzabolcsM J, et al. . Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis reduces remodeling and improves cardiac function. Nat Med, 2001, 7430-430

[11] OrlicD, KajsturaJ, ChimentiS, et al. . Mobilized bone marrow cells repair the infarcted heart, improving function and survival. PNAS, 2001, 9810344-10344

[12] MenascheP, HagegeA A, ScominM, et al. . Myoblast transplantation for heart failure. Lancet, 2001, 357279-279

[13] TomitaS, LiK R, WeiselR D, et al. . Autologous transplantation of bone marrow cell improves damaged heart function. Circulation, 1999, 100(sup II): 247-247

[14] SussmanM. Heart and bone. Nature, 2001, 410640-640

[15] OrlicD, KajsturaJ, ChimentiS, et al. . Bone marrow cell regenerate infarcted myocardium. Nature, 2001, 410701-701

[16] KoniecznyS F, EmersonC P. 5-azacytidine induction of stable mesodermal stem cell lineage from 10T 1/2 cells: Evidence for regulatory genes controlling determination. Cell, 1984, 38791-791